Indeed, supporting its clinical usefulness we and others have recently demonstrated that monitoring of WT1-mRNA expression levels in PB allows sensitive and specific detection of MRD after allo-SCT in a large proportion of MDS patients17,18,24. This evidence concerns the gene WT1 and myelodysplastic syndrome.